Schayowitz Adam
Reporting owner on Forms 3, 4 and 5, CIK 2127119.
Schayowitz Adam reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-09.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ZYME · Zymeworks Inc.CIK 1937653 | officer (EVP, Head of R&D) | 1 | 2026-10-09 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ZYME · Zymeworks Inc.Common Stock | 2026-10-09 | M exercised | +37,037 | $0 | 37,037 | Form 4 |
| ZYME · Zymeworks Inc.Common Stock | 2026-10-09 | S sold | -13,832 | $25.85 | 23,205 | Form 4 |
| ZYME · Zymeworks Inc.Restricted Stock Unit, derivative | 2026-10-09 | M exercised | -37,037 | $0 | 74,074 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002127119-26-000006 | Zymeworks Inc. | 2026-10-09 |